133 related articles for article (PubMed ID: 36502893)
1. Effect of valproate on sleep patterns disturbed by epilepsy.
Ayala-Guerrero F; Castro-Domínguez D; Mateos-Salgado EL; Mexicano-Medina G; Gutiérrez-Chávez CA
Physiol Behav; 2023 Feb; 259():114054. PubMed ID: 36502893
[TBL] [Abstract][Full Text] [Related]
2. Effect of gabapentin on sleep patterns disturbed by epilepsy.
Ayala-Guerrero F; Mexicano G; Gutiérrez-Chávez CA; Lazo LA; Mateos EL
Epilepsy Behav; 2019 Mar; 92():290-296. PubMed ID: 30731295
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of sodium valproate loaded nanoparticles in acute and chronic pentylenetetrazole induced seizure models.
Meenu M; Reeta KH; Dinda AK; Kottarath SK; Gupta YK
Epilepsy Res; 2019 Dec; 158():106219. PubMed ID: 31726286
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic interaction of hydroalcoholic extract of Ocimum sanctum with valproate.
Sarangi SC; Joshi D; Kumar R; Kaleekal T; Gupta YK
Epilepsy Behav; 2017 Oct; 75():203-209. PubMed ID: 28867572
[TBL] [Abstract][Full Text] [Related]
5. The blockade of transient receptor potential ankyrin 1 (TRPA1) protects against PTZ-induced seizure.
Heydari FS; Gorji Valokola M; Mehri S; Abnous K; Roohbakhsh A
Metab Brain Dis; 2023 Feb; 38(2):621-630. PubMed ID: 36399240
[TBL] [Abstract][Full Text] [Related]
6. The effect of co-administration of pentylenetetrazole with pilocarpine: New modified PTZ models of kindling and seizure.
Mousavi-Hasanzadeh M; Rezaeian-Varmaziar H; Shafaat O; Jand A; Palizvan MR
Pharmacol Biochem Behav; 2019 Jul; 182():7-11. PubMed ID: 31082418
[TBL] [Abstract][Full Text] [Related]
7. Magnesium supplementation enhances the anticonvulsant potential of valproate in pentylenetetrazol-treated rats.
Safar MM; Abdallah DM; Arafa NM; Abdel-Aziz MT
Brain Res; 2010 Jun; 1334():58-64. PubMed ID: 20353763
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of docosahexaenoic acid on anticonvulsant activity of valproic acid and lamotrigine in animal seizure models.
Gavzan H; Sayyah M; Sardari S; Babapour V
Naunyn Schmiedebergs Arch Pharmacol; 2015 Oct; 388(10):1029-38. PubMed ID: 26018398
[TBL] [Abstract][Full Text] [Related]
9. The antiepileptic effect of sodium valproate during different phases of the estrous cycle in PTZ-induced seizures in rats.
Kaboutari J; Zendehdel M; Habibian S; Azimi M; Shaker M; Karimi B
J Physiol Biochem; 2012 Jun; 68(2):155-61. PubMed ID: 22076911
[TBL] [Abstract][Full Text] [Related]
10. Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.
Löscher W
CNS Drugs; 2002; 16(10):669-94. PubMed ID: 12269861
[TBL] [Abstract][Full Text] [Related]
11. The potential effects of anticonvulsant drugs on neuropeptides and neurotrophins in pentylenetetrazol kindled seizures in the rat.
Tekgul H; Simsek E; Erdoğan MA; Yiğittürk G; Erbaş O; Taşkıran D
Int J Neurosci; 2020 Feb; 130(2):193-203. PubMed ID: 31518546
[No Abstract] [Full Text] [Related]
12. Calcitonin potentiates the anticonvulsant and antinociceptive effects of valproic acid and pregabalin in pentylenetetrazole-kindled mice.
Hamada NM; Ashour RH; Shalaby AA; El-Beltagi HM
Eur J Pharmacol; 2018 Jan; 818():351-355. PubMed ID: 29104044
[TBL] [Abstract][Full Text] [Related]
13. Acute and chronic effects of the synthetic neuroactive steroid, ganaxolone, against the convulsive and lethal effects of pentylenetetrazol in seizure-kindled mice: comparison with diazepam and valproate.
Gasior M; Ungard JT; Beekman M; Carter RB; Witkin JM
Neuropharmacology; 2000 Apr; 39(7):1184-96. PubMed ID: 10760361
[TBL] [Abstract][Full Text] [Related]
14. Kynurenic acid: a new effector of valproate action?
Maciejak P; Szyndler J; Turzyńska D; Sobolewska A; Płaźnik A
Pharmacol Rep; 2011; 63(6):1569-73. PubMed ID: 22358107
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of ghrelin, nesfatin-1 and irisin levels of serum and brain after acute or chronic pentylenetetrazole administrations in rats using sodium valproate.
Ergul Erkec O; Algul S; Kara M
Neurol Res; 2018 Nov; 40(11):923-929. PubMed ID: 30111257
[TBL] [Abstract][Full Text] [Related]
16. Intestinal inflammation increases convulsant activity and reduces antiepileptic drug efficacy in a mouse model of epilepsy.
De Caro C; Leo A; Nesci V; Ghelardini C; di Cesare Mannelli L; Striano P; Avagliano C; Calignano A; Mainardi P; Constanti A; Citraro R; De Sarro G; Russo E
Sci Rep; 2019 Sep; 9(1):13983. PubMed ID: 31562378
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant neuronal nitric oxide synthase inhibition for combined treatment of epilepsy and comorbid depression.
Singh T; Goel RK
Pharmacol Rep; 2017 Feb; 69(1):143-149. PubMed ID: 27923157
[TBL] [Abstract][Full Text] [Related]
18. 4-Phenylbutyric Acid Plus Valproic Acid Exhibits the Therapeutic and Neuroprotective Effects in Acute Seizures Induced by Pentylenetetrazole.
Rzayev E; Amanvermez R; Gün S; Tiryaki ES; Arslan G
Neurochem Res; 2022 Oct; 47(10):3104-3113. PubMed ID: 35764848
[TBL] [Abstract][Full Text] [Related]
19. The Search for New Screening Models of Pharmacoresistant Epilepsy: Is Induction of Acute Seizures in Epileptic Rodents a Suitable Approach?
Löscher W
Neurochem Res; 2017 Jul; 42(7):1926-1938. PubMed ID: 27502939
[TBL] [Abstract][Full Text] [Related]
20. [Stimulation of gastric mucosa afferents by phenylephrine potentiates anticonvulsive and eliminates sedative action of sodium valproate in the pentylenetetrazol kindling model in rats].
Serdiuk SE; Gmiro VE; Veselkina OS
Ross Fiziol Zh Im I M Sechenova; 2014 Jan; 100(1):96-104. PubMed ID: 25464725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
